Delamanid

Delamanid is an antibacterial medication used for the treatment of tuberculosis. It is specifically used, along with other tuberculosis medications, for active multidrug-resistant tuberculosis. It is taken by mouth.

Medical uses[edit | edit source]

Delamanid is used in combination with other antituberculosis medications to treat adults with multidrug-resistant tuberculosis (MDR-TB) when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.

Side effects[edit | edit source]

Common side effects include nausea, vomiting, and dizziness. Serious side effects may include QT prolongation and a type of irregular heart beat known as torsades de pointes.

Mechanism of action[edit | edit source]

Delamanid is a nitroimidazole antimycobacterial agent. It inhibits the synthesis of mycolic acids, thereby inhibiting the growth of Mycobacterium tuberculosis.

History[edit | edit source]

Delamanid was developed by Otsuka Pharmaceutical and approved for medical use in the European Union in April 2014.

Society and culture[edit | edit source]

As of 2016, delamanid is one of the newer medications used to treat tuberculosis. It is on the World Health Organization's List of Essential Medicines, the safest and most effective medicines needed in a health system.

References[edit | edit source]

Delamanid Resources
Need Help Finding a Doctor? Need help finding a doctor or specialist anywhere in the world? Explore our world directory. WikiMD's DocFinder can assist you in locating millions of physicians.	Medical Knowledge Access the latest research - Most recent articles Ongoing trials.